Purpose: The Ahmed FP-7 valve is useful in the management of refractory glaucoma. However, this can often have ocular hypertensive phase and subconjunctival fibrosis that can lead to increased medication use and failure. We report how retrobulbar and intraconal plate placement with tube extension can avoid the ocular hypertensive phase, lower intraocular pressure, and reduce medication burden.
Patients And Methods: This is a retrospective case series of 4 patients with glaucoma who underwent Ahmed FP-7 valve and retrobulbar/intraconal tube placement with a one-year follow-up.
Results: One-year results in 4 patients with advanced glaucoma and pseudophakia revealed a pre-operative intraocular pressure of 21 mmHg on 5.5 medications. At one year, the post-operative intraocular pressure was 10.25 on 0 medications. The vision and visual fields were stable. One patient required drainage of a choroidal effusion and one patient required burping of viscoelastic on post-operative day one.
Conclusions: The combined insertion of the Ahmed FP-7 valve and silicone tube inserted into the retrobulbar/intraconal space has been shown to prevent ocular hypertensive phase, lower intraocular pressure, and reduce medication burden at one year.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11893817 | PMC |
http://dx.doi.org/10.3389/fopht.2025.1408897 | DOI Listing |
Front Ophthalmol (Lausanne)
February 2025
Department of Ophthalmology, Advanced Eyecare of New York, New York, NY, United States.
Purpose: The Ahmed FP-7 valve is useful in the management of refractory glaucoma. However, this can often have ocular hypertensive phase and subconjunctival fibrosis that can lead to increased medication use and failure. We report how retrobulbar and intraconal plate placement with tube extension can avoid the ocular hypertensive phase, lower intraocular pressure, and reduce medication burden.
View Article and Find Full Text PDFJ AAPOS
October 2024
Department of Ophthalmology, Children's Hospital of Michigan, Detroit, Michigan; Wayne State University School of Medicine, Detroit, Michigan.
Graefes Arch Clin Exp Ophthalmol
June 2017
Icahn School of Medicine at Mount Sinai, New York Eye and Ear Infirmary of Mount Sinai, 310 East 14th Street, New York, NY, 10003, USA.
Purpose: 5-Fluorouracil (5-FU) has been well described for a failing trabeculectomy bleb, but not for aqueous shunts. We sought to determine whether subconjunctival 5-FU prolongs the intraocular pressure (IOP) efficacy of Ahmed shunts.
Methods: We included all patients with Ahmed FP-7 implantation by one surgeon at Yale University.
J Glaucoma
July 2016
*Athens Vision Eye Institute †2nd Ophthalmology Clinic, University of Athens, Attikon Hospital, Athens, Greece.
Purpose: To determine the safety and efficacy of fresh, human sclera allografts as a patch graft material in glaucoma drainage device (GDD) surgery.
Design: Retrospective, noncomparative, interventional, consecutive case series.
Subjects: All GDD cases operated between 2008 and 2013 in which fresh human corneoscleral rims were used immediately after the central corneal button was used for penetrating or endothelial keratoplasty.
PLoS One
February 2016
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, People's Republic of China.
Background: To evaluate the efficacy and safety of the Ahmed glaucoma valve (AGV) and the risk factors associated with AGV implantation failure in a population of Chinese patients with refractory glaucoma.
Method: In total, 79 eyes with refractory glaucoma from 79 patients treated in our institution from November 2007 to November 2010 were enrolled in this retrospective study. The demographic data, preoperative and postoperative intraocular pressures (IOPs), best corrected visual acuity (BCVA), number of anti-glaucoma medications used, completed and qualified surgery success rates and postoperative complications were recorded to evaluate the outcomes of AGV implantation.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!